Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Molecular Immunology|November 25, 2015
Chaperone BAG6 is dispensable for MHC class I antigen processing and presentationAnnegret Bitzer, Michael Basler, Marcus GroettrupMolecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.Clinical and Experimental Rheumatology|October 13, 2015
The immunoproteasome: a novel drug target for autoimmune diseasesMichael Basler, Sarah Mundt, Annegret Bitzer, et al.FEBS Letters|December 8, 2016
Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10Valentina Spinnenhirn, Annegret Bitzer, Annette Aichem, et al.Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Testing the Impact of Protease Inhibitors in Antigen Presentation AssaysMichael Basler, Marcus GroettrupMethods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Using protease inhibitors in antigen presentation assaysMichael Basler, Marcus GroettrupEuropean Journal of Immunology|March 16, 2007
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopesMichael Basler, Marcus GroettrupMethods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Immunoproteasome-specific inhibitors and their applicationMichael Basler, Marcus GroettrupDrugs & Aging|March 17, 2007
Advances in prostate cancer immunotherapiesMichael Basler, Marcus GroettrupCells|November 27, 2021
On the Role of the Immunoproteasome in Protein HomeostasisMichael Basler, Marcus GroettrupPageof 17